Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 272-712-1 | CAS number: 68909-77-3 The residuum from the reaction of diethylene glycol and ammonia. It consists predominantly of morpholine-based derivatives such as [(aminoethoxy)ethyl]morpholine, [(hydroxyethoxy)ethyl]morpholine, 3-morpholinone, and 4,4'-(oxydi-2,1-ethanediyl)bis[morpholine].
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010-10-25 to 2010-11-22
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- GLP study performed similar to OECD 407. No analyses of the dose formulations was performed, so no information is available on stability of the test substance in the dose formulations and the actual exposure concentrations.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Guidance for industry: M3 (R2) Non clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Deviations:
- yes
- Remarks:
- no analysis of the dose formulation samples was performed.
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine derivs. residues
- EC Number:
- 272-712-1
- EC Name:
- Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine derivs. residues
- Cas Number:
- 68909-77-3
- Molecular formula:
- Not applicable (UVCB)
- IUPAC Name:
- 2-(2-hydroxyethoxy)ethan-1-ol; 2-[1-(morpholin-4-yl)ethoxy]ethan-1-amine; 2-{2-[bis(2-hydroxyethyl)amino]ethoxy}ethan-1-ol; 4-{2-[2-(morpholin-4-yl)ethoxy]ethyl}morpholine; morpholin-3-one
- Test material form:
- liquid
- Details on test material:
- Name: Ethanol, 2,2'-oxybis-, reaction products with ammonia, morpholine derivs. residues
Physical state: liquid
Appearance: brown liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Amine C-8
- Physical state: dark liquid
- Analytical purity: no data
- Impurities (identity and concentrations): no data
- Lot/batch No.: not provided
- Expiration date of the lot/batch: no data
- Stability under test conditions: no data
- Storage condition of test material: room temperature, 10 to 25°C
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan
- Age at study initiation: ca. 7 weeks at start of dosing
- Weight at study initiation: 231-264 g for males and 166-189 g for females
- Fasting period before study: no
- Housing: Animals were group housed by sex upon receipt and individually housed upon assignment to study in compliance with National Research Council "Guide for the care and use of laboratory animals". The room in which the animals are kept is documented in the study records. No other species are kept in the same room.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: Study animals are acclimated to their housing for a minimum of 7 days prior to their first day of dosing.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16-22°C
- Humidity (%): 14-76%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark, except when room lights will be turned on during the dark cycle to accomodate blood sampling or other study procedures.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- deionized water
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS: the test article and vehicle control preparations are prepared weekly or additionaly as needed by diluting the test article in vehicle (w/v) to reach the proper concentrations.
Dose formulation samples: On the first and last day of dosing, duplicate 1-mL samples will be obtained from top, middle, and bottom of each formulation, including the vehicle control, to determine the concentration and homogeneity of the test article in vehicle. These samples are stored at room temperature, approximately 10 to 30°C.
Dose levels: 0, 100, 500, 1000 mg/kg bw/d
Concentration: 0, 10, 50, 100 mg/ml
Dose volume: 10 ml/kg - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- once daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- actual ingested
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Remarks:
- actual ingested
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Remarks:
- actual ingested
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Remarks:
- actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: The dose levels were selected by the sponsor in consultation with the Study Director
- Rationale for animal assignment: at random - Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily, once prior to scheduled sacrifices
- Cage side observations: each animal observed for evidence of death or impending death
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: prior to each dose administration, at approximately 1-2 hours post dose, and additionally as needed; once prior to scheduled sacrifice
BODY WEIGHT: Yes
- Time schedule for examinations: Body weights were recorded at the time of randomization/selection, prior to dose administration on Day 1 and weekly thereafter. A fasted body weight will be recorded before all scheduled sacrifices.
FOOD CONSUMPTION:
- Frequency: Full feeder weights and/or feeder weigh backs were recorded weekly for determination of food consumption.
HAEMATOLOGY: Yes / No / No data
- Time schedule for collection of blood: prior to terminal sacrifice on Day 29
- Anaesthetic used for blood collection: Yes (CO2 inhalation)
- Animals fasted: Yes (Animals will be fasted overnight (approximately 12-24 hours)
- Parameters checked: red blood cell count and morphology, white blood cell count, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, mean corpuscular volume, platelet count, hematocrit, hemoglobin, reticulocyte count, coagulation: activated partial thromboplastin time and prothrombin time
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: prior to terminal sacrifice on Day 29
- Anaesthetic used for blood collection: Yes (CO2 inhalation)
- Animals fasted: Yes (Animals will be fasted overnight (approximately 12-24 hours)
- Parameters checked: alanine aminotransferase, albumin, albumin/globulin ratio (calculated), alkaline phosphatase, aspartate aminotransferase, calcium, chloride, cholesterol, creatinine, globulin (calculated), glucose, phosphorus, potassium, sodium, total bilirubin, total protein, triglycerides, urea nitrogen - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
All surviving animals will be euthanized by CO2 asphyxiation following terminal blood collection on Day 29
Gross necropsy:
A complete gross necropsy was performed on all animals that were sacrificed or found dead during the study. The necropsy included examination of:
- the external body surface
- all orifices
- the cranial, thoracid and abdominal cavities and their contents
Organ weights: adrenals, brain, heart, kidneys, liver, testes, ovaries, spleen, thyroids/parathyroids
HISTOPATHOLOGY: Yes
For all animals necropsied, tissues were preserved in 10% neutral buffered formalin (except for the eyes, which were preserved in Davidson's fixative and the testes that were preserved in Bouin's fixed for optimum fixation). Tissues collected:
cardiovascular: aorta, heart;
digestive: salivary gland(s), tongue, esophagues, stomach, small intestine: duodenum, jejunum, ileum; large intestine: cecum, colon, rectum; pancreas, liver;
respiratory: trachea, larynx, lung with mainstem bronchus;
lymphoid/hematopoietic: sternum with bone marrow, thymus, spleen, lymph nodes, mandibular, mesenteric;
urogenital: kidneys, urinary bladder, ovaries, uterus, cervix, vagina, testes, epididymides, prostate, seminal vesicles;
endocrine: adrenals, pituitary, thyroid/parathyroid;
skin/musculoskeletal: skin, mammary gland, skeletal muscle (thigh), femur with articular surface;
nervous/special sense: eye with optic nerve, sciatic nerve, brain, spinal cord - cervical, spinal cord-midthoracic, spinal cord - lumbar, lacrimal glands - Statistics:
- Statistical analysis was performed on in-life data, clinical pathology, and necropsy data when 3 or more animals are present in 2 or more dose group. Statistical analysis were be performed if N< 3 animals per group. For in-life and clinical pathology parameters, the homogeneity of the data was determined by Bartlett's Test. If the data was homogeneous, a one-way analysis of variance was performed to assess statistical significance. If statistically significant differences between the means were found, Dunnett's test was used to determine the degree of significance for the control means (p<0.05, p<0.01), the Mann-Whitney U-Test was used to determine the degree of significance from the control means (p<0.05 and p<0.01). If only 2 dose groups were present for evaluation, the Mann-Whitney U-test was used to assess statistical significance between the 2 groups. For necropsy organ weight data, the evaluation of the equality of means was made by a one-way analysis of variance using the F distribution to assess statistical significance. If statistically significant differences between the means were found, Dunnett's test was used to determine the degree of significance from the control means (p<0.05 and p<0.01).
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- Statistically significant increases in absolute kidney weights (mid- and high-dose females), kidney-to-body weight ratio (high-dose females) and kidney-to-brain weight ratio (all dosed females).
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- not examined
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Target system / organ toxicity
- Key result
- Critical effects observed:
- no
Applicant's summary and conclusion
- Conclusions:
- Rats (5 per sex per dose) were exposed once daily to 0, 100, 500, 1000 mg/kg bw/d of test substance for 28 consecutive days. The only statistically significant effects in absolute and relative female kidney weights could not be related to any macroscopic or microscopic findings or changes in clinical chemistry parameters. There is thus no indication of kidney toxicity. The NOAEL was therefore considered to be 1000 mg/kg bw/d.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.